Purification specialist BIA Separations to become part of Sartorius

Göttingen Combination of businesses will create a premium portfolio for advanced therapies BIA Separations will be Sartorius’ center of excellence for purification of cell and gene therapeutics The life science company Sartorius announced today it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a [...]

INTRODUCING THE TESC-5133

Upgrade and simplify your laboratory testing with CANNON's new TESC-5133 Low Temperature Viscometer for engine lubricants that conforms, and automates, ASTM D5133 testing. The compact, economical TESC-5133 integrates and automates the ASTM D5133 process of conditioning and testing low temperature viscosities of engine lubricants. Common applications include: Gear oils Automatic transmission fluid Torque and tractor [...]

Spinlock announces the services and sales agreement with Zyzygy Inc.

Testimonial from Zyzygy: “This services and sales partnership is strongly aligned with the long term Technology Market Introduction strategy of our company” said Edgardo Promenzio, President and Technology Partner of Zyzygy Inc. “Partnering with Spinlock, a worldwide NMR equipment leader and highly innovative company, backed up by differentiated IP and an already strong presence in [...]

Phase Genomics Receives $3.9 Million through Two New Grants to Advance Human Health Diagnostics

SEATTLE -- Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of two NIH grants totaling $3.9M. The funds will be utilized to develop new, highly-scalable methods for detecting chromosomal rearrangements in diverse human samples. The adaptation of high-throughput proximity ligation (Hi-C) technology to cytogenomics promises to [...]

BC Platforms Announces Colorado Center for Personalized Medicine Joins Global Data Partner Network BCRQUEST.com to advance Personalized Healthcare Research

BC Platforms, a global leader in clinical and genomic data management, analytics and access, today announced that it has formed a new data partnership with the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus that will incorporate  clinical and genomic-consented records and biobank samples representing an ethnically diverse patient population [...]

DPX Technologies Announces a New INTip™ Size Exclusion Chromatography Product Line

Columbia, SC – DPX Technologies, a manufacturer of laboratory consumables for sample preparation, announces the development of a new product line for size exclusion chromatography. The technology is patent-pending and utilizes a novel INTip swelling method that supports a hands-off approach for size exclusion chromatography workflows. The automated INTip swelling process allows the gel resin [...]

SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine  SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader Company demonstrates solidity of its business model with banks joining in the [...]

New England Biolabs Expands its Luna® Portfolio with One-Step Master Mix for Multiplex RT-qPCR

IPSWICH, Mass. -- New England BioLabs, Inc.® (NEB®) today announced the launch of its Luna Probe One-Step RT-qPCR 4X Mix with UDG, which is optimized for the sensitive detection of target RNA sequences for probe-based applications, and allows for increased throughput by multiplexing up to five targets. The new master mix consolidates all essential components [...]

Food and Drug Administration Renews and Expands Use of Certara’s Biosimulation Software for Reviewing Regulatory Submissions

FDA’s Office of Pharmaceutical Quality adds new licenses of Simcyp™ Simulator PRINCETON, N.J.— Certara, a global leader in biosimulation, today announced that the U.S. Food and Drug Administration (FDA) has again renewed and expanded its licenses of Certara’s biosimulation software, with more than 400 user licenses of Simcyp™ and Phoenix™ platforms. Eleven divisions and offices of [...]

Navigo Proteins and Repligen Announce Achievement of a Key Milestone in Development of an Affinity Resin for the Purification of COVID-19 Vaccines

HALLE (Saale), Germany, and WALTHAM, Mass, USA -- Navigo Proteins GmbH (“Navigo”), a premier protein engineering company specializing in novel affinity ligand development, and Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership today announced their successful development of an affinity ligand targeting the SARS-CoV‑2 spike protein, to be utilized in the purification of [...]

Access IBO on Knowledge Center